FIGS (NYSE:FIGS – Free Report) had its price target lowered by Telsey Advisory Group from $17.00 to $16.00 in a research note released on Friday, MarketBeat reports. The brokerage currently has a market perform rating on the stock.
FIGS has been the topic of several other reports. BTIG Research upped their price target on FIGS from $20.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday. KeyCorp boosted their target price on shares of FIGS from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Friday. Weiss Ratings downgraded shares of FIGS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, May 13th. Zacks Research lowered shares of FIGS from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 8th. Finally, Barclays lifted their price target on shares of FIGS from $17.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $18.71.
Read Our Latest Research Report on FIGS
FIGS Stock Performance
FIGS (NYSE:FIGS – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.02. FIGS had a return on equity of 12.65% and a net margin of 8.72%.The firm had revenue of $159.90 million during the quarter, compared to analyst estimates of $153.15 million. The company’s quarterly revenue was up 28.0% compared to the same quarter last year. On average, analysts predict that FIGS will post 0.26 earnings per share for the current year.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in FIGS. Bank of America Corp DE boosted its holdings in FIGS by 190.3% in the first quarter. Bank of America Corp DE now owns 790,013 shares of the company’s stock worth $11,668,000 after acquiring an additional 517,918 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of FIGS by 13.9% during the first quarter. The Manufacturers Life Insurance Company now owns 60,354 shares of the company’s stock valued at $891,000 after acquiring an additional 7,348 shares in the last quarter. Castleark Management LLC bought a new position in shares of FIGS during the first quarter valued at $2,939,000. Entropy Technologies LP purchased a new position in shares of FIGS in the 1st quarter worth about $606,000. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of FIGS by 167.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 4,070,258 shares of the company’s stock worth $60,118,000 after purchasing an additional 2,546,905 shares during the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.
Key FIGS News
Here are the key news stories impacting FIGS this week:
- Positive Sentiment: Quarterly results exceeded expectations. FIGS reported second-quarter revenue of approximately $196.6 million, up 28.8% year over year and ahead of the $186.2 million consensus estimate. Adjusted earnings were reported at $0.15 per share versus analyst expectations of $0.07 and $0.04 in the prior-year quarter. FIGS Releases Second Quarter 2026 Financial Results
- Positive Sentiment: Management raised its full-year outlook. FIGS issued 2026 revenue guidance of approximately $757.3 million, above the $729.1 million Wall Street consensus. The improved outlook signals continued demand for its healthcare apparel and supports expectations for faster growth. Figs shares jump after strong second-quarter results and higher 2026 outlook
- Positive Sentiment: Share repurchases added another support. FIGS increased its buyback authorization, potentially enhancing per-share earnings and signaling management confidence in the company’s valuation and cash-generation outlook. Figs rallies on impressive growth, upbeat outlook, and increased buyback
- Positive Sentiment: BTIG became more bullish. BTIG Research raised its price target from $20 to $22 and reiterated a “buy” rating, reflecting increased confidence in FIGS’ growth trajectory. Benzinga analyst note
- Neutral Sentiment: Analyst opinion remains mixed. Telsey Advisory Group lowered its target from $17 to $16 and kept a “market perform” rating, suggesting the recent rally may have already priced in much of the earnings improvement. The Fly analyst note
FIGS Company Profile
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
Further Reading
- Five stocks we like better than FIGS
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
